Tech Reporter Virgin Islands: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Reporter Virgin Islands.

Press releases published on March 9, 2026

Mar. 9, 2026

Capricor Therapeutics to Present Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Update on March 12

Indeterminate GlobeNewswire

Mar. 9, 2026

Pelthos Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results on March 19, 2026

Indeterminate GlobeNewswire

Mar. 9, 2026

Profound Medical to Host Investor Call to Discuss First Clinical Outcomes from the CAPTAIN Trial on March 13; Participate in ROTH Investor Conference on March 22-24

Indeterminate GlobeNewswire

Mar. 9, 2026

Jet.AI Inc. Reports Full Year 2025 Financial Results

Indeterminate GlobeNewswire

Mar. 9, 2026

UPDATE – Visionary Doubles Down on High-Margin Medical Aesthetics with US$12 Million Exclusive Agreement, Initiates Strategic Exit from Non-Core Businesses

Indeterminate GlobeNewswire

Mar. 9, 2026

NovelMed Therapeutics Announces Regulatory Clearance for Subcutaneous Ruxoprubart and Reports Positive Phase II Intravenous Monotherapy Results in PNH

Indeterminate GlobeNewswire

Mar. 9, 2026

Aurora Mobile's EngageLab Launches OpenClaw Skills, Empowering AI Agents to Connect with the Real World

Indeterminate GlobeNewswire

Mar. 9, 2026

Chiesi Global Rare Diseases and Protalix BioTherapeutics Announce European Commission Approval of Additional Dosing Regimen of Every Four Weeks for Elfabrio® (pegunigalsidase alfa) ▼

Indeterminate GlobeNewswire

Mar. 9, 2026

Acronis Releases 2025 ESG Report Highlighting Progress in Sustainability, Workforce Engagement, and Responsible Technology

Indeterminate GlobeNewswire

Mar. 9, 2026

Candel Therapeutics To Present New Data after Extended Follow Up from Randomized Phase 3 Trial of Aglatimagene Besadenovec in Localized Prostate Cancer at the American Urological Association 2026 Annual Meeting

Indeterminate GlobeNewswire

Mar. 9, 2026

Sangamo Therapeutics Advances Rolling Submission of BLA to U.S. FDA for ST-920 in Fabry Disease

Indeterminate GlobeNewswire

Mar. 9, 2026

Nasus Pharma to Present and Participate in the Upcoming Life Sciences Investor Forum

Indeterminate GlobeNewswire

Mar. 9, 2026

Mirai Robotics raises $4.2M pre-seed to build autonomous and intelligent maritime systems to master every sea

Indeterminate GlobeNewswire

Mar. 9, 2026

SpyGlass Pharma Announces Positive Topline 12-Month Phase 1/2 Trial Results for Its Innovative BIM-IOL System

Indeterminate GlobeNewswire

Mar. 9, 2026

LB Pharmaceuticals Appoints R&D Biotech Executive Robert Lenz, M.D., Ph.D. to Board of Directors

Indeterminate GlobeNewswire

Mar. 9, 2026

Galecto Announces Name Change to Damora Therapeutics with Mission to Fundamentally Redefine Care for Patients with Blood Disorders

Indeterminate GlobeNewswire

Mar. 9, 2026

Cue Biopharma to Present New In vitro Data for CUE-401 at the 20th World Immune Regulation Meeting (WIRM) 2026

Indeterminate GlobeNewswire

Mar. 9, 2026

MBX Biosciences Announces Successful End-of-Phase 2 FDA Meeting and Provides Phase 3 Development Plan for Once-Weekly Canvuparatide for Hypoparathyroidism

Indeterminate GlobeNewswire

Mar. 9, 2026

First Subjects Dosed in Cocrystal Pharma’s Phase 1b Study Evaluating CDI-988 for Norovirus Prevention and Treatment

Indeterminate GlobeNewswire

Mar. 9, 2026

electroCore to Announce Fourth Quarter and Full Year Ended December 31, 2025, Financial Results on Thursday, March 19, 2026

Indeterminate GlobeNewswire